AAAAAA

   
Results: 1-8 |
Results: 8

Authors: Ringe, B Lorf, T Dopkens, K Canelo, R
Citation: B. Ringe et al., Treatment of hepatic metastases from gastroenteropancreatic neuroendocrinetumors: Role of liver transplantation, WORLD J SUR, 25(6), 2001, pp. 697-699

Authors: Ringe, B Braun, F Schutz, E Fuzesi, L Lorf, T Canelo, R Oellerich, M Ramadori, G
Citation: B. Ringe et al., A novel management strategy of steroid-free immunosuppression after liver transplantation: Efficacy and safety of tacrolimus and mycophenolate mofetil, TRANSPLANT, 71(4), 2001, pp. 508-515

Authors: Braun, F Lorf, T Schutz, E Canelo, R Hanack, U Dopkens, K Sattler, B Grupp, C Ringe, B
Citation: F. Braun et al., Primary tacrolimus immunosuppression in kidney recipients considered "higher immunological risk", TRANSPLAN P, 32(7), 2000, pp. 1688-1688

Authors: Braun, F Lorf, T Schutz, E Canelo, R Hanack, U Dopkens, K Sattler, B Grupp, C Ringe, B
Citation: F. Braun et al., Primary tacrolimus immunosuppression in kidney recipients considered "higher immunologic risk", TRANSPLAN P, 32(7), 2000, pp. 2535-2535

Authors: Canelo, R Braun, F Dopkens, K Ramadori, G Ringe, B
Citation: R. Canelo et al., Characterization and influence of risk factors on initial liver function after transplantation, TRANSPLAN P, 32(1), 2000, pp. 60-61

Authors: Braun, F Canelo, R Lorf, T Schutz, E Grupp, C Muller, GA Ringe, B
Citation: F. Braun et al., Living-related versus living-unrelated kidney transplantation using tacrolimus initial immunosuppression, TRANSPLAN P, 32(1), 2000, pp. 115-116

Authors: Canelo, R Braun, F Sattler, B Klinge, B Lorf, T Ramadori, G Ringe, B
Citation: R. Canelo et al., Is a fatty liver dangerous for transplantation?, TRANSPLAN P, 31(1-2), 1999, pp. 414-415

Authors: Braun, F Canelo, R Schutz, E Shipkora, M Lorf, T Hanack, U Niedmann, D Armstrong, VW Oellerich, M Ringe, B
Citation: F. Braun et al., How to handle mycophenolate mofetil in combination with tacrolimus?, TRANSPLAN P, 30(8), 1998, pp. 4094-4095
Risultati: 1-8 |